Thermosensitive Nanosystems Associated with Hyperthermia for Cancer Treatment
Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Pharmaceuticals (Basel, Switzerland) - 12(2019), 4 vom: 25. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pereira Gomes, Isabela [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer treatment |
|---|
| Anmerkungen: |
Date Revised 27.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/ph12040171 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM303775033 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM303775033 | ||
| 003 | DE-627 | ||
| 005 | 20240327234649.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ph12040171 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1350.xml |
| 035 | |a (DE-627)NLM303775033 | ||
| 035 | |a (NLM)31775273 | ||
| 035 | |a (PII)E171 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pereira Gomes, Isabela |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Thermosensitive Nanosystems Associated with Hyperthermia for Cancer Treatment |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful drug development platform. Encapsulation of antitumor drug(s) in thermosensitive nanocarriers is an emerging approach with a promise to improve uptake and increase therapeutic efficacy, as they can be activated by hyperthermia selectively at the tumor site. In this review, we focus on thermosensitive nanosystems associated with hyperthermia for the treatment of cancer, in preclinical and clinical use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a cancer treatment | |
| 650 | 4 | |a hyperthermia | |
| 650 | 4 | |a thermosensitive systems | |
| 700 | 1 | |a Aparecida Duarte, Jaqueline |e verfasserin |4 aut | |
| 700 | 1 | |a Chaves Maia, Ana Luiza |e verfasserin |4 aut | |
| 700 | 1 | |a Rubello, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Townsend, Danyelle M |e verfasserin |4 aut | |
| 700 | 1 | |a Branco de Barros, André Luís |e verfasserin |4 aut | |
| 700 | 1 | |a Leite, Elaine Amaral |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceuticals (Basel, Switzerland) |d 2009 |g 12(2019), 4 vom: 25. Nov. |w (DE-627)NLM199619514 |x 1424-8247 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2019 |g number:4 |g day:25 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ph12040171 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2019 |e 4 |b 25 |c 11 | ||